Loading...
Hofseth BioCare ASA
HOFBF•PNK
Healthcare
Biotechnology
$0.17
$0.00(0.00%)
Hofseth BioCare ASA (HOFBF) Financial Performance & Income Statement Overview
Review Hofseth BioCare ASA’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
32.09%
↑ 32.09%
Operating Income Growth
-10.41%
↓ 10.41%
Net Income Growth
-15.67%
↓ 15.67%
Operating Cash Flow Growth
-455.72%
↓ 455.72%
Operating Margin
-39.50%
↓ 39.50%
Gross Margin
34.46%
↑ 34.46%
Net Profit Margin
-46.52%
↓ 46.52%
ROE
-154.13%
↓ 154.13%
ROIC
-57.35%
↓ 57.35%
Hofseth BioCare ASA (HOFBF) Income Statement & Financial Overview
Review Hofseth BioCare ASA's (HOFBF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $64.97M | $67.89M | $80.41M | $52.10M |
| Cost of Revenue | $45.57M | $49.01M | $47.62M | $53.42M |
| Gross Profit | $19.40M | $18.87M | $32.79M | -$1.33M |
| Gross Profit Ratio | $0.30 | $0.28 | $0.41 | -$0.03 |
| R&D Expenses | $0.00 | $0.00 | $1.24M | $1.25M |
| SG&A Expenses | $0.00 | $0.00 | $22.65M | $23.90M |
| Operating Expenses | $56.07M | $49.42M | $36.15M | $24.88M |
| Total Costs & Expenses | $101.65M | $98.43M | $91.98M | $78.31M |
| Interest Income | $774000.00 | $7000.00 | $8000.00 | $1000.00 |
| Interest Expense | $4.63M | $4.14M | $3.64M | $3.28M |
| Depreciation & Amortization | $10.68M | $9.53M | $9.59M | $8.74M |
| EBITDA | -$26.52M | -$21.34M | -$4.33M | -$17.47M |
| EBITDA Ratio | -$0.41 | -$0.31 | -$0.05 | -$0.34 |
| Operating Income | -$36.67M | -$30.54M | -$11.57M | -$26.21M |
| Operating Income Ratio | -$0.56 | -$0.45 | -$0.14 | -$0.50 |
| Other Income/Expenses (Net) | -$5.15M | -$4.47M | -$6.00M | -$2.80M |
| Income Before Tax | -$41.82M | -$35.01M | -$17.56M | -$28.20M |
| Income Before Tax Ratio | -$0.64 | -$0.52 | -$0.22 | -$0.54 |
| Income Tax Expense | -$1.94M | $0.00 | $0.00 | $810000.00 |
| Net Income | -$41.82M | -$35.01M | -$17.56M | -$29.007M |
| Net Income Ratio | -$0.64 | -$0.52 | -$0.22 | -$0.56 |
| EPS | -$0.10 | -$0.09 | -$0.04 | -$0.07 |
| Diluted EPS | -$0.10 | -$0.08 | -$0.04 | -$0.07 |
| Weighted Avg Shares Outstanding | $411.08M | $411.08M | $411.08M | $410.38M |
| Weighted Avg Shares Outstanding (Diluted) | $412.08M | $412.25M | $411.08M | $410.38M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan